St. Louis, Missouri – DYNALABS is pleased to announce that the American Association for Laboratory Accreditation (A2LA) has approved our company for ISO/IEC 17025 accreditation. To gain the accreditation, DYNALABS underwent a thorough assessment of its quality management processes, and competency to perform analytical and microbiological testing on pharmaceutical raw materials and compounded drug products.
The ISO/IEC accreditation certifies an organization’s competence to manage and perform the activities defined by its A2LA Scope of Accreditation (Certificate #3841.01).
“DYNALABS is honored to become 1 of only 4 US laboratories with the 17025 accreditation that provide chemical and microbiological services to compounding pharmacies, API manufacturers, and regulatory agencies. Our business model is based on excellent Quality Systems, and a focus on partnering with our customers for continuous improvement. This recognition really sets us apart from other contract laboratories.” CARLA KUTZ, Director of Quality
At DYNALABS, patient safety is at the center of everything we do. We are the only analytical testing lab services company that can help hospital and other compounding pharmacies achieve … and surpass … their goals for patient safety.
A2LA is the largest U.S.-based, multi-discipline accreditation body with over 35 years of experience providing internationally recognized accreditation services and quality training. A2LA’s world-class accreditation services encompass testing and calibration laboratories, medical testing laboratories, inspection bodies, proficiency testing providers, reference material producers and product certification bodies. Organizations are accredited to international standards and field-specific requirements developed with government and industry collaboration. A2LA also offers a wide variety of both public and private on-site training programs to complement the various accreditation programs.
DYNALABS is based in St. Louis, Missouri, and has over 12 years of experience helping pharmacies and pharmaceutical suppliers address the many regulatory and business challenges associated with delivering high-quality products to the marketplace. Our highly-qualified and experienced U.S.-based staff will work with you to identify best-practices that both ensure patient safety, and minimize liability to your business. DYNALABS is your trusted partner in assuring and continually improving quality, reducing costs, and optimizing patient safety.
DYNALABS LLC is FDA-registered; DEA and Bureau of Narcotics and Dangerous Drugs licensed, as well as ISO 17025 certified. Services provided by DYNALABS are protected by U.S. Patents Number 7,197,405 & 7,660,678.